Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,331
New position
Shares Held
50
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#569
of 663 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Synergy Investment Management, LLC holds $193,142 across 13 Biotechnology names. INSM ranks #4 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
255 | $126,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
62 | $38,658 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
24 | $7,224 | |
| 4 | INSM |
INSMED Inc
This page
|
50 | $5,331 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
80 | $2,831 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
32 | $2,608 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
35 | $2,002 | |
| 8 | ABVX |
Abivax S.A.
|
15 | $1,998 |
All Filings in INSM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,331 | 50 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||